3136 results for «2962»
3136 results
Complex distal left main bifurcation lesion
04 Jul 2019 – From AICT-AsiaPCR 2019
A 75-year-old male with multiple risk factors and a history of NSTEMI is admitted for staged PCI to his left main bifurcation. His vessels are diffusely calcified…
TAVI in a bicuspid aortic valve stenosis
05 Jul 2019 – From AICT-AsiaPCR 2019
Watch this LIVE demonstration from Clinique Pasteur (France) to learn about the case of a 81 years-old male patient with dyslipidemia referred to the hospital because of NYHA II shortness of breath related to a severe aortic stenosis. CT scan revealed a type I L-R bicuspid...
Calcified left main lesion PCI
05 Jul 2019 – From AICT-AsiaPCR 2019
Consult this session to discover the key clinical data and angiographic reference of a patient presenting with calcified left main lesion PCI.
AICT-AsiaPCR Opening Ceremony
04 Jul 2019 – From AICT-AsiaPCR 2019
Consult this session to watch AICT-AsiaPCR 2019 Opening Ceremony, led by Jean Fajadet. Discover the missions of PCR, and the novelties offered by the AICT-AsiaPCR course, arising from the Asia-Pacific region and showcasing its clinical research and innovations.
LAD/D1 bifurcation disease
06 Jul 2019 – From AICT-AsiaPCR 2019
Consult this session to discover the key clinical data and angiographic reference of a patient presenting with LAD/D1 bifurcation disease.
How to optimise clinical outcomes with the latest generation intra-annular self-expandable TAVI device?
08 Feb 2025 – From PCR Tokyo Valves 2025
Discover the latest advancements in TAVI procedures with this PCR Tokyo Valves 2025 session replay, where leading experts share key strategies to enhance patient outcomes. This session explores how to select the optimal index valve for lifetime management, reduce pacemaker rates with the latest intra-annular self-expanding...
TAVI in small annulus - LIVE case
08 Feb 2025 – From PCR Tokyo Valves 2025
A 79-year-old female with CAD (stenosis in the mid-LAD), asthma, and diabetes presented with symptomatic severe aortic stenosis. Left ventricular function was preserved, with an annulus measuring 355 mm², and the valves were heavily calcified.
A Navitor Vision valve was implanted with predilatation (18 mm balloon) under...
Lifetime management - First valve choice matters
08 Feb 2025 – From PCR Tokyo Valves 2025
In this expert-led session, explore new frontiers in TAVI, focusing on bicuspid aortic valves, small annulus, and the risk of secondary interventions. Gain insights from the latest randomized trials (RHEIA) and registry data (CAvEAT), with real-world case discussions highlighting their clinical impact.
Lifetime management
08 Feb 2025 – From PCR Tokyo Valves 2025
This PCR Tokyo Valves 2025 session explores the latest insights into TAVR explantation. It begins with the management of patients with longer life expectancy, then delves into surgical aortic valve replacement, aortic root enlargement, and commissural alignment—key techniques that may improve reintervention outcomes. The session also...
Management of paravalvular leak
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore this comprehensive session on the management of paravalvular leaks, a challenging complication following surgical or transcatheter valve replacements. Discover insights into managing post-operative pulmonary edema, percutaneous closure of left ventricular septal defects, and the nuances of mitigating recurrent paravalvular leaks. Dive into complex cases involving...
TAV-in-TAV
08 Feb 2025 – From PCR Tokyo Valves 2025
Watch this PCR Tokyo Valves 2025 session on TAV-in-TAV to discover essential insights on optimizing the procedure. Learn how CT analysis and precise measurements are critical for success, and why coronary protection, chimney stenting, and leaflet modification must be considered in high-risk cases. Experts discuss key...
TAVI and coronary artery disease
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the complex interplay between TAVI and coronary artery disease in this comprehensive session. Explore the decision-making process for optimal sequencing of PCI and TAVI, and examine cases of acute myocardial infarction due to coronary embolism and delayed coronary obstruction following TAVI. Gain insights into...
TAVI complex cases: intravascular hemolysis, Heyde syndrome & more
08 Feb 2025 – From PCR Tokyo Valves 2025
This session presents a diverse array of complex TAVI cases, from interventions for paravalvular leak-induced intravascular hemolysis to cases of severe aortic tortuosity, calcification hindering valve expansion, and successful TAVI in patients with Heyde syndrome and HIV infection. Gain valuable insights into navigating these challenging scenarios.
High-risk TAVI
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the management of high-risk TAVI cases in this session. Discover innovative approaches, such as Impella-assisted TAVI in severe bicuspid aortic valve disease with severe left ventricular dysfunction, TAVR for pure native aortic regurgitation in surgically unfit patients, and the use of TAVI as a...
The value of WATCHMAN therapy - Who should we treat?
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the value of WATCHMAN therapy in this sponsored session by Boston Scientific. Explore the latest evidence and future perspectives of this innovative treatment option. Understand who the ideal patient is for WATCHMAN therapy and how to identify them in daily clinical practice, including TAVI...
Mitral valve-in-valve and valve-in-ring electrosurgery
08 Feb 2025 – From PCR Tokyo Valves 2025
Future devices for structural heart interventions
08 Feb 2025 – From PCR Tokyo Valves 2025
Get a glimpse into the future of structural heart interventions! This PCR Tokyo Valves 2025 session dives into the latest innovations in imaging and explores groundbreaking devices for mitral and tricuspid valve treatments. Watch as experts discuss how these advancements are set to reshape clinical practice.
Nightmare in TAVI
08 Feb 2025 – From PCR Tokyo Valves 2025
Watch this session replay featuring two challenging cases: valve embolisation with a balloon-expandable valve and coronary obstruction with a self-expandable valve. Learn key lessons from the first case, including the importance of secure pacing, avoiding damage to the descending aorta while retrieving the embolised valve, and...
M-TEER for secondary mitral regurgitation
08 Feb 2025 – From PCR Tokyo Valves 2025
Managing secondary mitral regurgitation with M-TEER requires a tailored approach. This PCR Tokyo Valves 2025 session explores key considerations for atrial functional MR and VFMR beyond COAPT criteria, helping you refine patient selection, procedural strategies, and post-treatment management through expert insights and real-world cases.
Mitral complications
08 Feb 2025 – From PCR Tokyo Valves 2025
